Test Price
650 AED✅ Home Collection Available
Canavan Disease (Aspartoacylase Deficiency) Screening Test, Urine | 650 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Overview
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Lab (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily 8 AM–11 PM.
- Clinical Guidance: Complimentary telephonic post-test consultation with DHA-licensed Consultant Medical Genetics.
- Insurance Verification: Direct billing support via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This urine-based test quantifies N-acetylaspartic acid (NAA) to screen for Canavan disease, a severe inherited leukodystrophy caused by aspartoacylase deficiency. It employs advanced LC-MS/MS technology validated against global metabolomic databases for superior accuracy.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Methodology | LC-MS/MS (Gold Standard) | GC-MS or Spectrophotometry (older) |
| Turnaround Time | 5 working days | 7–14 days |
| Sample Collection | VIP Mobile Phlebotomy & Cold-Chain Home Visit (8 AM–11 PM) | Clinic or hospital visit required |
| Price | 650 AED | Varies (often higher) |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Genetics (Lina Osama Zaki Quteineh, DHA: 9294403), I emphasize that an elevated NAA result requires correlation with clinical symptoms and genetic validation. This test is not a standalone diagnosis; please discuss findings with your specialist before drawing conclusions. We are here to support you every step.”
Advisory Notice
⚠️ Medication Warning:
Do not discontinue any prescribed medication, including anti-epileptics or nutritional supplements, without consulting your doctor. Stopping treatment abruptly may worsen symptoms.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Acute febrile illness or active infection (postpone collection).
- Recent (<48h) administration of contrast dyes or medications that interfere with creatinine (e.g., trimethoprim, cimetidine).
- Severe dehydration or oliguria – ensure adequate hydration.
- Contaminated sample (fecal, blood) – recollect with sterile container.
Emergency Red Flags for Immediate Medical Attention:
- Infant exhibiting sudden lethargy, vomiting, or seizures.
- Rapidly enlarging head circumference (>2 SD) with sunsetting eyes.
- Loss of previously acquired developmental milestones.
Patient FAQ & Clinical Guidance
1. What exactly does the Canavan disease urine test measure?
A: It measures N-acetylaspartic acid (NAA) concentration in urine, a key biomarker for aspartoacylase deficiency. Elevated NAA confirms the metabolic block typical of Canavan disease, aiding early diagnosis in symptomatic infants or borderline newborn screening results.
2. How is the urine sample collected at home, and is it safe for my baby?
A: A trained phlebotomist visits your home with sterile pediatric urine bags and cold-chain storage to ensure safety. No invasive procedure is needed; the collection is painless and takes less than 15 minutes, adhering to strict infection control.
3. When will I receive the results, and who will explain them to me?
A: Results are delivered within 5 working days; a DHA-licensed Consultant Medical Genetics will call you for clinical interpretation. You can schedule a teleconsultation to discuss implications and next steps regarding your child’s health.
UAE Regulatory & Data Privacy Adherence
All diagnostic processes at DNA Labs UAE comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient confidentiality and data security are enforced through encrypted storage, controlled access, and strict consent protocols. Clinical safety and patient rights are further governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Canavan Disease (Aspartoacylase Deficiency) Screening Test, Urine |
| Price (AED) | 650 AED |
| Turnaround Time | 5 working days |
| Sample Type / Matrix | Urine (random void) |
| Methodology Used | LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) |
| ICD-10-CM Code | E75.29, Z13.228, R82.998 |
| LOINC Code | 22690-4 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians